Tuesday, 15 April 2014





Introducing Mysore University Courses at ACRI
As the Indian population grows at the rate of 1.5% every year, the requirement for the jobs will drastically increase. As a result of this, government spending will increase in various sectors and one of them is Pharma & Clinical research.

As per as McKinsey report, government spending in healthcare will increase significantly. It has been growing at 18% annually since 2005 to 2006, and is translating into a higher level of access in Tier-II and rural markets.


Secondly, there would be a demand for new therapies and innovative drugs due to aggressive players in market. 

Sl. No.
THERAPIES
GROWTH
1
OTC/Self-medicate
Growth over 14% annually
2
Biologics
3 billion segment by 2020
3
Vaccines
20 per cent over the next decade

In the base case scenario, all the important growth drivers will observe vigorous progress. The market will grow more than four times to reach USD 55 billion by 2020. 


As the Indian population grows, the prevalence of diseases like diabetes, cancer, heart disease etc. will also show drastic increase.


Insurance coverage would grow to cover the entire Indian population below the poverty line.




Moreover, the players will influence the patient funnel by increasing awareness and treatment, thereby increasing the patient pool by 15 percent.



Beyond numbers, new skill requirements will also increase the attractiveness of talent from Pharma and non-Pharma backgrounds. The Post Graduate Diploma in Clinical Research and Clinical Database Management program at ACRI (Mysore University) invites BSc, MSc in life science and health science to join the course and enjoy different opportunities’ offered by Pharma and CR industry.

No comments:

Post a comment